Kalana P Maduwage1, Fiona E Scorgie2, Lisa F Lincz2, Margaret A O'Leary3, Geoffrey K Isbister4. 1. Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; South Asian Clinical Toxicology Research Collaboration, University of Peradeniya, Peradeniya, Sri Lanka. Electronic address: kalanapm@gmail.com. 2. Hunter Haematology Research Group, Calvary Mater Newcastle, Newcastle, NSW, Australia. 3. Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia. 4. Clinical Toxicology Research Group, University of Newcastle, Newcastle, Australia; South Asian Clinical Toxicology Research Collaboration, University of Peradeniya, Peradeniya, Sri Lanka.
Abstract
BACKGROUND: Animal models are used to test toxic effects of snake venoms/toxins and the antivenom required to neutralise them. However, venoms that cause clinically relevant coagulopathy in humans may have differential effects in animals. We aimed to investigate the effect of different procoagulant snake venoms on various animal plasmas. METHODS: Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer levels were measured in seven animal plasmas (human, rabbit, cat, guinea pig, pig, cow and rat). In vitro clotting times were then used to calculate the effective concentration (EC50) in each plasma for four snake venoms with different procoagulant toxins: Pseudonaja textilis, Daboia russelli, Echis carinatus and Calloselasma rhodostoma. RESULTS: Compared to human, PT and aPTT were similar for rat, rabbit and pig, but double for cat and cow, while guinea pig had similar aPTT but double PT. Fibrinogen and D-dimer levels were similar for all species. Human and rabbit plasmas had the lowest EC50 for P. textilis (0.1 and 0.4 μg/ml), D. russelli (0.4 and 0.1 μg/ml), E. carinatus (0.6 and 0.1 μg/ml) venoms respectively, while cat plasma had the lowest EC50 for C. rhodostoma (11 μg/ml) venom. Cow, rat, pig and guinea pig plasmas were highly resistant to all four venoms with EC50 10-fold that of human. CONCLUSIONS: Different animal plasmas have varying susceptibility to procoagulant venoms, and excepting rabbits, animal models are not appropriate to test procoagulant activity. In vitro assays on human plasma should instead be adopted for this purpose.
BACKGROUND: Animal models are used to test toxic effects of snake venoms/toxins and the antivenom required to neutralise them. However, venoms that cause clinically relevant coagulopathy in humans may have differential effects in animals. We aimed to investigate the effect of different procoagulant snake venoms on various animal plasmas. METHODS:Prothrombin time (PT), activated partial thromboplastin time (aPTT), fibrinogen and D-dimer levels were measured in seven animal plasmas (human, rabbit, cat, guinea pig, pig, cow and rat). In vitro clotting times were then used to calculate the effective concentration (EC50) in each plasma for four snake venoms with different procoagulant toxins: Pseudonaja textilis, Daboia russelli, Echis carinatus and Calloselasma rhodostoma. RESULTS: Compared to human, PT and aPTT were similar for rat, rabbit and pig, but double for cat and cow, while guinea pig had similar aPTT but double PT. Fibrinogen and D-dimer levels were similar for all species. Human and rabbit plasmas had the lowest EC50 for P. textilis (0.1 and 0.4 μg/ml), D. russelli (0.4 and 0.1 μg/ml), E. carinatus (0.6 and 0.1 μg/ml) venoms respectively, while cat plasma had the lowest EC50 for C. rhodostoma (11 μg/ml) venom. Cow, rat, pig and guinea pig plasmas were highly resistant to all four venoms with EC50 10-fold that of human. CONCLUSIONS: Different animal plasmas have varying susceptibility to procoagulant venoms, and excepting rabbits, animal models are not appropriate to test procoagulant activity. In vitro assays on human plasma should instead be adopted for this purpose.
Authors: Kalana Maduwage; Anjana Silva; Margaret A O'Leary; Wayne C Hodgson; Geoffrey K Isbister Journal: Sci Rep Date: 2016-05-27 Impact factor: 4.379
Authors: Leijiane F Sousa; Christina N Zdenek; James S Dobson; Bianca Op den Brouw; Francisco Coimbra; Amber Gillett; Tiago H M Del-Rei; Hipócrates de M Chalkidis; Sávio Sant'Anna; Marisa M Teixeira-da-Rocha; Kathleen Grego; Silvia R Travaglia Cardoso; Ana M Moura da Silva; Bryan G Fry Journal: Toxins (Basel) Date: 2018-10-11 Impact factor: 4.546
Authors: Bianca Op den Brouw; Francisco C P Coimbra; Lachlan A Bourke; Tam Minh Huynh; Danielle H W Vlecken; Parviz Ghezellou; Jeroen C Visser; James S Dobson; Manuel A Fernandez-Rojo; Maria P Ikonomopoulou; Nicholas R Casewell; Syed A Ali; Behzad Fathinia; Wayne C Hodgson; Bryan G Fry Journal: Toxins (Basel) Date: 2021-02-02 Impact factor: 4.546
Authors: Rahini Kakumanu; Barbara K Kemp-Harper; Anjana Silva; Sanjaya Kuruppu; Geoffrey K Isbister; Wayne C Hodgson Journal: Sci Rep Date: 2019-12-27 Impact factor: 4.379